Aims: The small Heat Shock Protein B8 (HSPB8) is the core component of the chaperone-assisted selective autophagy (CASA) complex. This complex selectively targets, transports, and tags misfolded proteins for their recognition by autophagic receptors and insertion into autophagosome for clearance. CASA is essential to maintain intracellular proteostasis, especially in heart, muscle, and brain often exposed to various types of cell stresses. In neurons, HSPB8 protects against neurotoxicity caused by misfolded proteins in several models of neurodegenerative diseases; by facilitating autophagy, HSPB8 assists misfolded protein degradation also counteracting proteasome overwhelming and inhibition. Materials and Methods: To enhance HSPB8 protective activity, we screened a library of approximately 120,000 small molecules to identify compounds capable of increasing HSPB8 gene transcription, translation, or protein stability. We found 83 compounds active in preliminary dose-response assays and further classified them in 19 chemical classes by medicinal chemists' visual inspection. Of these 19 prototypes, 14 induced HSPB8 mRNA and protein levels in SH-SY5Y cells. Key findings: Out of these 14, 3 successfully reduced the aggregation propensity of a disease-associated mutant misfolded Superoxide Dismutase 1 (SOD1) protein in a flow cytometry-based “aggregation assay” [Flow cytometric analysis of Inclusions and Trafficking” (FloIT)] and induced the expression (mRNA and protein) of some autophagy receptors. Notably, the 3 hits were inactive in HSPB8-depleted cells, confirming that their protective activity is mediated by and requires HSPB8. Significance: Thus, these compounds may be highly relevant for a therapeutic approach in several human disorders, including neurodegenerative diseases, in which enhancement of CASA exerts beneficial activities.

Identification of HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases / M. Chierichetti, M. Cerretani, A. Ciammaichella, V. Crippa, P. Rusmini, V. Ferrari, B. Tedesco, E. Casarotto, M. Cozzi, F. Mina, P. Pramaggiore, M. Galbiati, M. Piccolella, A. Bresciani, R. Cristofani, A. Poletti. - In: LIFE SCIENCES. - ISSN 0024-3205. - 322:(2023 Jun 01), pp. 121323.1-121323.18. [10.1016/j.lfs.2022.121323]

Identification of HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases

M. Chierichetti
Primo
;
V. Crippa;P. Rusmini;V. Ferrari;B. Tedesco;E. Casarotto;M. Cozzi;F. Mina;P. Pramaggiore;M. Galbiati;M. Piccolella;R. Cristofani
Penultimo
;
A. Poletti
Ultimo
2023

Abstract

Aims: The small Heat Shock Protein B8 (HSPB8) is the core component of the chaperone-assisted selective autophagy (CASA) complex. This complex selectively targets, transports, and tags misfolded proteins for their recognition by autophagic receptors and insertion into autophagosome for clearance. CASA is essential to maintain intracellular proteostasis, especially in heart, muscle, and brain often exposed to various types of cell stresses. In neurons, HSPB8 protects against neurotoxicity caused by misfolded proteins in several models of neurodegenerative diseases; by facilitating autophagy, HSPB8 assists misfolded protein degradation also counteracting proteasome overwhelming and inhibition. Materials and Methods: To enhance HSPB8 protective activity, we screened a library of approximately 120,000 small molecules to identify compounds capable of increasing HSPB8 gene transcription, translation, or protein stability. We found 83 compounds active in preliminary dose-response assays and further classified them in 19 chemical classes by medicinal chemists' visual inspection. Of these 19 prototypes, 14 induced HSPB8 mRNA and protein levels in SH-SY5Y cells. Key findings: Out of these 14, 3 successfully reduced the aggregation propensity of a disease-associated mutant misfolded Superoxide Dismutase 1 (SOD1) protein in a flow cytometry-based “aggregation assay” [Flow cytometric analysis of Inclusions and Trafficking” (FloIT)] and induced the expression (mRNA and protein) of some autophagy receptors. Notably, the 3 hits were inactive in HSPB8-depleted cells, confirming that their protective activity is mediated by and requires HSPB8. Significance: Thus, these compounds may be highly relevant for a therapeutic approach in several human disorders, including neurodegenerative diseases, in which enhancement of CASA exerts beneficial activities.
HSPB8; cancer; neurodegenerative disorders; neuromuscular disorders; chaperone-assisted selective autophagy; proteasome
Settore BIO/13 - Biologia Applicata
Settore BIO/09 - Fisiologia
   Selective translation of androgen receptor isoform A to prevent polyQ mediated toxicity in Kennedy’s disease
   MLOMALS
   KENNEDY'S DISEASE ASSOCIATION

   Alternative translation initiation as a novel strategy to block toxicity of the mutant Androgen Receptor in SBMA
   Target-RAN
   FONDAZIONE TELETHON ETS
   GGP19128

   Unveiling regenerative and metabolic features of SBMA muscle cells to identify new therapeutic targets
   EX_ALS
   KENNEDY'S DISEASE ASSOCIATION

   Role of CHIP/STUB1 in the clearance of toxic proteins responsible for repeat expansion neurodegenerative diseases
   TEAM
   FONDAZIONE CARIPLO
   2021-1544

   Membrane-less organelle pathology in ALS: identification of causes and rescuing factors (MLOMALS)
   Co-ALS
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA

   Targeting RAN translation in ALS (Target-RAN)
   Target-RAN
   FONDAZIONE ITALIANA DI RICERCA PER LA SLA - SCLEROSI LATERALE AMIOTROFICA - ARISLA

   The involvement of the small heat shock protein HSPB8 in amyotrophic lateral sclerosis
   AFM-TELETHON - ASS. FRANCAISE CONTRE LES MYOPATHIES

   The interplay between the “rna/protein quality control system” and “exosomes” as a spreading mechanism in amyotrophic lateral sclerosis (EX_ALS)
   EX_ALS
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2017F2A2C5_001

   Role of TDP-43 self-assembly in health and disEase: molecular characteristics, cellular Aspects and animal Models
   TEAM
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2020PBS5MJ_005

   Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial (Co-ALS)
   Co-ALS
   AGENZIA ITALIANA DEL FARMACO - AIFA
   AIFA-2016-02364678

   National Center for Gene Therapy and Drugs based on RNA Technology
   MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
   CN00000041
1-giu-2023
24-dic-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0024320522010232-main.pdf

accesso aperto

Descrizione: In Press, Journal Pre Proof
Tipologia: Publisher's version/PDF
Dimensione 10.14 MB
Formato Adobe PDF
10.14 MB Adobe PDF Visualizza/Apri
1-s2.0-S0024320522010232-main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 7.12 MB
Formato Adobe PDF
7.12 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/949710
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact